Synthesis of Iron Based Biocompatible Metal Organic Frameworks for Microencapsulation of Docetaxel

Abstract:

Tunable properties of porous metal organic frameworks (MOFs) make them a potential candidate for sustained release of functionally active biomolecules. Current study describes in situ encapsulation of anti-cancer drug, docetaxel in iron based MOFs for drug delivery applications. MOFs were synthesized using emulsification approach by mixing FeCl₃.4H₂O and benzene tricarboxylate (BTC) in 1:1 molar ratio in the presence of cetyl trimethyl ammonium bromide (CTAB). Optical characterization of the NMOFs was done using UV-visible and FTIR spectroscopy. The peak obtained at 265 nm in the UV-visible spectrum indicated the formation of iron-based NMOF. The peaks obtained at 3416, 1623 and 3343cm^-1 corresponding to C=O, C=C and C=O groups in FTIR spectroscopy further supported our observations. Microencapsulation of docetaxel was achieved by mixing the drug with the iron salt during the synthesis of MOF. Drug encapsulation was affirmed by Transmission Electron Microscopy. Current study is an attempt in exploring the microencapsulation properties of MOFs.

• Periodical: Nano Hybrids and Composites (Volume 12)
• Pages: 74-78
• DOI: https://doi.org/10.4028/www.scientific.net/NHC.12.74
• Online since: November 2016
• Authors: Tanvi Sharma*, Harpreet Kaur, Amandeep Kaur, Mandeep Singh, Navdeep Kaur, Mukesh Kanwar, Deepak Kukkar
• Keywords: BTC, Docetaxel, Iron Chloride, Metal Organic Framework, Microencapsulation

References

[1] S. Svenson and D. Tomalia, Dendrimers in biomedical applications—reflections on the field, Advanced Drug Delivery Reviews, 2005, vol. 57, 2106–2129.

DOI: 10.1016/j.addr.2005.09.018

[2] Caskey, S. R, Matzger, A.J., Chae, H. K.; Siberio-Pérez, D. Y.; Kim, J.; Go, Y, Material Matters, 2009, vol. 4, 111-123.

[3] Krause, M. Environmental Science and Technology; (2007).

[4] Eddaoudi, M.; Matzger, A. J.; O'Keeffe, M.; Yaghi, O. M. Nature, Tools for designing high performance MOFs. (2004), 427-523.

[5] Poshow kathryn; Rocca D., Xie Zhigang , postsynthetic for drug delivery, (2001)14261-14263.

[6] Ali mubarak; Nasir S., Sahoo , metal ion affinity biomolecules Iron terypyridine, (2010), 17307-17315.

[7] Horcajada Patricia; Serre. C, G. Maurin, F. Balas, Flexible porous Mof's for a controlled drug delivery, (2009), vol-130/6774-6780.

DOI: 10.1021/ja710973k

[8] Li, S.D. and Huang, L. Mol Pharm 2008 (5): 496-504.

[9] Coombs, R.R.H. and Robinson, D.W. Gordon & Breach, ISBN 1996 2-88449-080-9.

[10] Kurmoo, M. Chem Soc Rev 2009 (38): 1353–1379.

[11] Dechambenoit, P and Long, J.R. Chem Soc Rev 2011 (40): 3249–3265.

[12] Horcajada, P., Gref,R., Baati, T et al. Chem Rev 2012 (112): 1232–1268.

[13] Huxford, R. C and Lin, W. Curr Opin Chem Biol 2010 (14): 262–268.

[14] Bhushan, B. Springer 2nd Edition 2007 ISBN-10: 3-540-29855-X: 4.

[15] Qimeng Quan , Jin Xie , Haokao Gao, 1669-1676.

[16] Yuanjing, Cui. Banglin, Chena and Guodong, Qian. Coordination Chemistry Reviews, Elsevier 2014 (273-274): 76-86.

[17] Yaghi, O.M., and Hailian, Li. Nature 1999 (402): 276-279.

[18] Misty, D. Rowe, Douglas, H. Thamm., Susan, L. Kraft and Stephen, G. Boyes. Biomacromolecules 2009 (10): 983–993.